| # | Drug | Count |
|---|---|---|
| 0 | DEXAMETHASONE | 28 |
| 1 | DEXAMETHASONE 1.5 MG | 28 |
| 2 | CYCLOPHOSPHAMIDE | 26 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 26 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 26 |
| 5 | PREDNISONE | 24 |
| 6 | CYTARABINE | 23 |
| 7 | DOXORUBICIN | 20 |
| 8 | CISPLATIN | 16 |
| 9 | VANCOMYCIN | 15 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MITOXANTRONE HYDROCHLORIDE | 12 | 0.0019 |
| 1 | VANCOMYCIN HYDROCHLORIDE | 15 | 0.0018 |
| 2 | CEFOTAXIME INJECTION | 5 | 0.0011 |
| 3 | AMIKACIN SULFATE | 2 | 0.0011 |
| 4 | AMPICILLIN AND SULBACTAM | 1 | 0.0011 |
| 5 | ACYCLOVIR SODIUM | 1 | 0.0008 |
| 6 | METHENAMINE HIPPURATE | 1 | 0.0008 |
| 7 | BRENTUXIMAB VEDOTIN | 7 | 0.0007 |
| 8 | CLADRIBINE | 6 | 0.0006 |
| 9 | ALBENDAZOLE | 1 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 53 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 36 |
| 2 | Platinum-based Drug [EPC] | 36 |
| 3 | Alkylating Drug [EPC] | 29 |
| 4 | Microtubule Inhibitor [EPC] | 19 |
| 5 | Glycopeptide Antibacterial [EPC] | 15 |
| 6 | Leukocyte Growth Factor [EPC] | 14 |
| 7 | Proteasome Inhibitor [EPC] | 14 |
| 8 | Topoisomerase Inhibitor [EPC] | 14 |
| 9 | Nitroimidazole Antimicrobial [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD30-directed Immunoconjugate [EPC] | 7 | 0.0007 |
| 1 | Anthelmintic [EPC] | 1 | 0.0003 |
| 2 | Asparagine-specific Enzyme [EPC] | 4 | 0.0003 |
| 3 | Penem Antibacterial [EPC] | 10 | 0.0003 |
| 4 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 5 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 2 | 0.0002 |
| 6 | Glycopeptide Antibacterial [EPC] | 15 | 0.0002 |
| 7 | Antiparasitic [EPC] | 1 | 0.0002 |
| 8 | Pediculicide [EPC] | 1 | 0.0002 |
| 9 | Progestin Antagonist [EPC] | 1 | 0.0002 |